Kynam Capital Management LP 13D and 13G filings for Vera Therapeutics, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2024-11-14 12:15 pm Sale | 2024-09-30 | 13G | Vera Therapeutics, Inc. VERA | Kynam Capital Management LP | 1,576,549 2.490% | -2,073,790 (-56.81%) | Filing |
| 2024-02-14 12:49 pm Purchase | 2023-12-31 | 13G | Vera Therapeutics, Inc. VERA | Kynam Capital Management LP | 3,650,339 8.220% | 2,241,241 (+159.06%) | Filing |
| 2023-02-10 1:20 pm Purchase | 2022-12-30 | 13G | Vera Therapeutics, Inc. VERA | Kynam Capital Management LP | 1,409,098 5.100% | 1,409,098 (New Position) | Filing |